Skip to Main Content

Yale SPORE in Lung Cancer

Yale SPORE in Lung Cancer

Yale School of MedicineYale Cancer Center
SPORE in Lung Cancer

Building a Powerhouse Team To Tackle Lung Cancer

Open the document

Yale SPORE in Lung Cancer News

October 07, 2020
Yale Cancer Center Researchers Report Results of Afatinib plus Cetuximab for Treatment of EGFR-Mutant NSCLC
Read more
October 01, 2020
Immunotherapy Drug Boosts Survival for Lung Cancer Patients
Source: U.S. News & World Report
Read more
October 01, 2020
Atezolizumab Appears Effective for Patients with NSCLC with High PD-L1 Expression
Source: Cancer Network
Read more
September 24, 2020
Yale Cancer Center Awarded NIH SPORE for Head and Neck Cancer Research
Read more
September 19, 2020
Yale Cancer Center Study Reinforces Benefit Using Targeted Therapy for Early Stage NSCLC
Read more

Maps & Directions
Calendar
Contact Us

Intranet
Site Editor
Accessibility at YSM
Terms & Privacy Policy
Yale University
Yale Phonebook

© 2020 Yale School of Medicine. Updated 08/13/2019

Your browser is antiquated and no longer supported on this website. Please update your browser or switch to Chrome, Firefox or Safari.
You can update your IE here:
https://support.microsoft.com/en-us/help/17621/internet-explorer-downloads